abstract |
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase ninhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine nkinase (BTK).The invention also contemplates the use of the compounds for treating conditions n5 treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and nimmunological diseases. |